Recommendations for therapy of tobacco dependence;Empfehlungen zur therapie von tabakabhängigkeit

Suchtmedizin in Forschung und Praxis

Volumn 3, Issue 3, 2001, Pages 156-175

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CLONIDINE; LOBELINE; MECAMYLAMINE; NICOTINE; NORTRIPTYLINE;

ACUPUNCTURE; AVERSION; CARDIOTOXICITY; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; HUMAN; HYPNOSIS; NEUROTOXICITY; PATHOPHYSIOLOGY; REVIEW; TINNITUS; TOBACCO DEPENDENCE;

EID: 0034786690     PISSN: 14375567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (286)

1. Cigarette smoking: An epidemiological overview
2. Surveillance for selected tobacco-use behaviours - United States, 1900 1994
3. Rauchen: Gesundheitswesen und politik im wechselspiel
4. The fight against tobacco in developing countries
5. Aktives und passives rauchen
6. Entschließung des 99. Deutschen ärztetages 1996
7. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system
8. Mortality from smoking worldwide
9. Tumorerkrankungen als folge des rauchens
10. Comparison of cancer mortalità trends in major European areas, 1960-89
11. The costs of health damage and productivity losses attributable to cigarette smoking in Germany
12. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies
13. Nikotine dependence versus smoking prevalance among countries and categories of smokers
14. Neue aspekte der nikotinabhängigkeit und raucherentwöhnung
15. Measuring nicotine dependence: A review of the Fagerström Tolerance Questionaire
16. Health risks associated with cigar smoking
17. Nikotine metabolism defect reduces smoking
18. Tobacco smoking, genes and dopamine
19. Case control study of the D2 dopamine receptor gene and smoking status in lung cancer patients
20. Repräsentativerheburg zum gebrauch psychoaktiver substanzen bei erwachsenen in Deutschland 1997
21. Stages and processes of selfchange of smoking: Toward an integrative model of change
22. Individual behavioural counselling for smoking cessation
23. Self-help interventions for smoking cessation
24. Evaluation of intrinsic and extrinsic motivation interventions with a self-help smoking cessation program
25. Quitting smoking now or later: Gradual, abrupt, immediate or delayed quitting
26. Self-help books and amount of therapist contact in smoking cessation programs
27. Smoking cessation - Gradual or sudden stopping?
28. Physician advice for smoking cessation
29. How to help your patients to stop smoking
30. Training physicians in counseling about smoking cessation
31. The impact of physicians' brief smoking cessation counseling
32. Controlled trial of three different antismoking interventions in general practice
33. Subject characteristics and long-term post-program smoking cessation
34. Increasing the efficacy of physician-delivered smoking interventions: A randomized clinical trial
35. Smoking cessation in family practice: The effects of advice and nicotine chewing gum prescription
36. Counselling against cigarette smoking
37. Effect of general practitioners' advice against smoking
38. The effectiveness of two smoking cessation programmes for use in general practice: A randomised clinical trial
39. The impact of routine advice on smoking cessation from family physicians
40. Can residents be trained to counsel patients about quitting smoking?
41. Effectiveness of smoking cessation interventions integrated into primary care practice
42. Smoking prevention among people aged 60 and over: A randomised controlled trial
43. Sick of smoking: Evaluation of a targeted minimal smoking cessation intervention in general practice
44. Encouraging primary care physicians to help smokers quit
45. Training physicians about smoking cessation: A controlled trial in private practice
46. Randomised trial of nicotine patches in general practice: Results at one year
47. A family physician smoking cessation program: An evaluation of the role of follow-up visits
48. Broad-spectrum behavioral approach to smoking cessation: Effects of social support and paraprofessional training on the maintenance of treatment effects
49. The effects of a multiple treatment program and maintenance procedures on smoking cessation
50. Smoking cessation in patients: Two further studies by the British Thoracic Society
51. A smoking cessation program for use in general practice
52. Adding spirometry, carbon monoxide, and pulmonary symptom results to smoking cessation counseling: A randomized trial
53. A randomized trial of smoking cessation interventions in general practice in Italy
54. Randomized clinical trial of supportive follow-up for cigarette smokers in a family practice
55. Nursing interventions for smoking cessation
56. Smoking cessation after acute myocardial infarction: Effects of a nursemanaged intervention
57. A comparison of nursing interventions for smoking cessation in adults with cardiovascular health problems
58. Group behaviour therapy programmes for smoking cessation
59. Partner support, psychological treatment, and nicotine gum in smoking treatment: An incremental study
60. Aversive smoking for smoking cessation
61. Potential hazards of rapid smoking as a technic for the modification of smoking behavior
62. Smoking deterrence using silver acetate
63. Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation
64. Silver acetate gum as a deterrent to smoking
65. Silver acetate mouth spray as an aid in smoking cessation: Results of a double-blind trial
66. Silver acetate for smoking cessation
67. Acupuncture and hypnosis compared: Fifty-eight cases
68. Variables of hypnosis which are related to success in a smoking withdrawal program
69. Comparison of hypnotherapy with systematic relaxation in the treatment of cigarette habituation
70. The use of hypnosis in 1000 cases of tobaccomaniacs
71. Comparison of hypnosis plus counseling, counseling alone, and hypnosis alone in a community service smoking withdrawal program
72. Use of single session hypnosis for smoking cessation
73. Hypnotherapy for smoking cessation
74. Helping people to stop smoking: Randomised comparison of groups being treated with acupuncture and nicotine gum with control group
75. Smoking cessation with behaviour therapy or acupuncture: A controlled study
76. Acupuncture and group therapy in stopping smoking
77. Desintoxication tabagique: Acupuncture et traitement medical: Resultats compares à 1 an sur 130 cas
78. Acupuncture for smokers: Lack of long-term therapeutic effect in a controlled study
79. Etude de l'action specifique de l'acupuncture dans la cure de sevrage tabagique
80. Acupuncture for smoking cessation
81. The effectiveness of the nicotine patch for smoking cessation
82. Nikotine replacement therapy for smoking cessation
83. Metaanalysis on efficacy of nicotine replacement therapy in smoking cessation
84. The effectiveness of nicotine replacement therapy in helping people to stop smoking
85. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum
86. Mood management and nicotine gum in smoking treatment - A therapeutic contact and placebo-controlled study
87. Nikotine gum and self-help manuals in smoking cessation: An evaluation in a medical context
88. Effect of dose on nicotine's reinforcing withdrawal-suppression and self reported effects
89. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
90. Nikotine patch and self-help video for cigarette smoking cessation
91. Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial
92. Effect of transdermal nicotine delivery as an adjunct to low intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study
93. Pharmacotherapy of nicotine dependence
94. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice
95. Importance of baseline cotinine plasma value in smoking cessation: Results from a double blind study with nicotine patch
96. Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation
97. Combined use of nicotine patch and gum compared with gum alone in smoking cessation: A clinical trial in North Karelia
98. Nikotine nasal spray with nicotine patch for smoking cessation. Randomized trial with six year follow up
99. Circadian blood nicotine concentrations during cigarette smoking
100. Nikotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum
101. Comparison of the nicotine pharmacokinetics of nicoderm (nicotine transdermal system) and half-hourly cigarette smoking
102. Transdermal nicotine
103. Nikotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia
104. Cholesterol changes in smoking cessation using the transdermal nicotine system
105. A placebo controlled study assessing the safety and relative efficacy of two delivery rates of a new transdermal nicotine system
106. A placebo-controlled study assessing the safety and efficacy of TTS (nicotine) in patients with coronary artery disease
107. A placebo controlled study assessing the safety and relative efficacy of three delivery rates of a new transdermal nicotine system
108. Subgroups of smokers with different success rates after use of transdermal nicotine
109. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials
110. Die behandlung von schwerabhängigen rauchern mit nikotinpflaster und nikotinnasenspray
111. A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation
112. Recent developments in the study of the effects of cigarette smoking on clinical pharmacokinetics and clinical pharmacodynamics
113. State of the Art - Smoking tobacco, microcirculatory changes and the role of nicotine
114. Cigarette smoking, nicotine and pregnancy
115. Smoking cessation through the use of nicotine chewing gum: A double-blind trial in Thailand
116. Stopping smoking: Do nicotine chewing-gum and postal encouragement add to doctors' advice?
117. Effectiveness of negative practice and self-control techniques in the reduction of smoking behavior
118. A comparison of psychological and pharmacological treatment in smoking cessation
119. Effects of nicotine chewing gum and followup appointments in physician-based smoking cessation
120. A controlled trial of nicotine chewing gum in a smoking withdrawal clinic
121. Nikotine gum and self help behavioral treatment for smoking relapse prevention results from a trial using population-based recruitment
122. Smoking cessation in primary care. A randomised controlled trial of nicotine-bearing chewing gum
123. Nikotine gum and behavioural treatment in smoking cessation
124. Nikotine gum and behavioural treatment: A placebo controlled trial
125. Nikotine gum, 2 and 4 mg, for nicotine dependence. A double-blind placebo-controlled trial within a behavior modification support program
126. Effect of nicotine chewing gum in smoking cessation. A randomized, placebo-controlled, double-blind study
127. Nikotine vs placebo gum in general medical practice
128. Evaluation of a treatment approach combining nicotine gum with self guided behavioural treatments for smoking relapse prevention
129. Nikotine gum and self regulation training in smoking relapse prevention
130. Nikotine chewing gum in general practice: Effect of follow up appointments
131. An assessment of nicotine gum as an adjunct to freedom from smoking cessation clinics
132. A clinical trial of nicotine chewing gum for smoking cessation
133. Nikotine gum vs. placebo gum: Comparisons of withdrawal symptoms and success rates
134. Randomized trial of brief individual treatment for smoking using nicotine chewing gum in a workplace setting
135. Smoking intervention in the workplace using videotapes and nicotine chewing gum
136. Effect of nicotine chewing gum in combination with group counseling in the cessation of smoking
137. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments
138. Controlled trial of nicotine polacrilex gum with supportive measures
139. A double blind study of 2 mg versus 4 mg nicotine-gum in an industrial setting
140. Nikotine containing chewing gum in smoking cessation: A double blind trial with half year followup
141. General Practitioner interventions for smoking cessation: Past results and future prospects
142. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking
143. Controlled trial of transdermal nicotine patch in tobacco withdrawal
144. Effectiveness of a transdermal nicotine system in smoking cessation studies
145. Smoking cessation among inner-city African-Americans using the nicotine transdermal patch
146. Combination of behavioural smoking cessation with transdermal nicotine substitution
147. Transdermal nicotine plus support in patients attending hospital with smoking-related diseases: A placebo-controlled study
148. High-dose nicotine patch therapy - Percentage of replacement and smoking cessation
149. Entwöhnung junger raucher mit hilfe eines transdermalen nikotinpflasters
150. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments
151. Double blind trial of a repeated transdermal treatment nicotine for relapsed smokers
152. Combined and separate treatment effects of nicotine chewing gum and self control method
153. Nikotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: One-year outcome and percentage of nicotine replacement
154. Nikotinereplacement therapy with use of a transdermal nicotine patch a randomised double-blind placebo-controlled trial
155. Placebo controlled trial of nicotine chewing gum in general practice
156. Degree of addiction and effectiveness of nicotine gum therapy for smoking
157. Randomised controlled trial of nicotine chewing-gum
158. The effect of nicotine, silver acetate, and placebo chewing gum on the cessation of smoking. The influence of smoking type and nicotine dependence
159. Varying nicotine patch dose and type of smoking cessation counseling
160. Predicting smoking cessation: Who will quit with and without the nicotine patch
161. Treatment of smoking: A comparison between supportive therapy and therapy using support, nicotine chewing gum and behavior reinforcement
162. The use of nicotine chewing gum as an aid to stopping smoking
163. Effect of nicotine chewing gum in smoking cessation classes
164. Does nurse counselling or offer of nicotine gum improve the effectiveness of physician smoking-cessation advice?
165. The transdermal nicotine patch: Results of a randomised placebo-controlled trial
166. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioral program: One year outcome
167. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counselling
168. Nikotine patches in smoking cessation: A randomized trial among overthecounter customers in Denmark
169. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation
170. The nicotine patch in smoking cessation. A randomised trial with telephone-counseling
171. Effect of nicotine nasal spray on smoking cessation. A randomized, placebocontrolled, double-blind study
172. Efficacy of a nicotine nasal spray in smoking cessation: A placebo-controlled, double-blind trial
173. Randomised controlled trial of nasal nicotine spray in smoking cessation
174. The nicotine inhaler in smoking cessation
175. Efficacy of the nicotine inhaler as an adjunct to smoking cessation
176. Efficacy of a nicotine inhaler in smoking cessation: A double-blind, placebo controlled mal
177. A double-blind trial of a nicotine inhaler for smoking cessation
178. The long-term effect of nicotine on the oral mucosa
179. Anxiolytics and antidepressants for smoking cessation
180. Efficacy of bupropion for smoking cessation in non depressed smokers
181. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride
182. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism
183. A comparison of sustainedrelease bupropion and placebo for smoking cessation
184. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
185. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
186. A randomized trial of nortriptyline for smoking cessation
187. Mecamylamine (a nicotine antagonist) for smoking cessation
188. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone
189. Nikotinemecamylamine treatment for smoking cessation: The role of pre-cessation therapy
190. Lobeline for smoking cessation
191. Ergebnisse der entwöhnung von 1125 rauchern. Ein beitrag zum abhängigkeitsproblem von nikotin
192. Clonidine for smoking cessation
193. Clonidine helps cigarette smokers stop smoking
194. The effect of clonidine on the cessation of cigarette smoking
195. Randomized, controlled trial of clonidine for smoking cessation in a primary care setting
196. Heavy smokers, smoking cessation, and clonidine
197. Results of a controlled study of clonidine vs placebo for cessation of smoking
198. Double-blind, placebo-controlled evaluation of transdermal clonidine in smoking cessation
199. Lack of efficacy of transdermal clonidine in a smoking cessation class
200. Transdermal clonidine reduced some withdrawal symptoms but did not increase smoking cessation
201. Transdermal clonidine for smoking cessation: A randomized trial
202. Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms
203. A placebocontrolled evaluation of the effects of buspirone on smoking cessation: Differences between high- and low-anxiety smokers
204. Comparison of fixed-dose transdermal nicotine, tapered-dose transdermal nicotine, and buspirone in smoking cessation
205. Buspirone effect on tobacco withdrawal symptoms: A randomized placebo-controlled trial
206. Efficacy of buspirone in smoking cessation: A placebocontrolled trial
207. Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic
208. Development of major depressive disorder during smoking-cessation treatment
209. Weight suppression and weight rebound in ex-smokers treated with fluoxetine
210. Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients
211. Mood, major depression, and fluoxetine response in cigarette smokers
212. Doxepin as an adjunct to smoking cessation: A double-blind pilot study
213. Fluoxetine not associated with increased aggression in controlled clinical trials
214. Antidepressant pharmaco-therapy helps some cigarette smokers more than others
215. Effects of doxepin on withdrawal symptoms in smoking cessation
216. Effects of fluoxetine on weight gain and food intake in smokers who reduce nicotine intake
217. Doxepin in smoking cessation
218. A prospective safety surveillance study for Bupropion sustainedrelease in the treatment of depression
219. Development of depression during placebo-controlled trials of bupropion for smoking cessation: Case reports
220. Bupropion mimics a transient ischemic attack
221. Pharmacotherapy for smoking cessation
222. A randomised controlled trial of the effect on middle-aged men of advice to stop smoking
223. Stopping smoking after myocardial infarction
224. The clinician's role in promoting smoking cessation among clinic patients
225. Effect of diet and smoking intervention on the incidence of coronary heart disease
226. Multiple Risk Factor Intervention Trial: Risk factor changes mortality results
227. Multifactorial trial in the prevention of coronary heart disease II: Risk factor changes at two and four years
228. Smokeless tobacco use and atherosclerosis: An ultrasonographic investigation of carotid intima media thickness in healthy middleaged men
229. Nikotine replacement therapy for patients with coronary artery disease
230. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking
231. Don't forget nicotine replacement therapy in smokers with cardiovascular disease
232. Early smoking initiation and nicotine dependence in a cohort of young adults
233. Cigarette smoking: Implications for psychiatric illness
234. Smoking and mental illnes. A population-based prevalence study
235. Psychiatric comorbidity of smoking and nicotine dependence
236. Smoking and major depression: A causal analysis
237. Depression and dynamics of smoking
238. Comorbidity between depressive disorders and nicotine dependence in a cohort of 16-year-olds
239. Investigation of mechanisms linking depressed mood to nicotine dependence
240. Breast feeding and maternal smoking as predictors of wheezing in children age 6 to 10 years
241. A randomised trial of a serialized self-help smoking cessation program for pregnant women in an HMO
242. Stopping smoking in pregnancy: Effect of a self-help manual in controlled trial
243. A clinical trial of change in maternal smoking and its effect on birth weight
244. The effectiveness of smoking cessation methods for smokers in public health maternity clinics: A randomized trial
245. Health education for pregnant smokers: Its behavioural impact and cost benefit
246. A randomised evaluation of smoking cessation interventions for pregnant women at a WIC clinic
247. A comparison of two antismoking interventions among pregnant women in eleven private primary care practices
248. Self-help smoking cessation and maintenance programs: A comparative study with 12-month follow-up by the American Lung Association
249. A randomized trial of a self-help smoking cessation intervention in a nonvolunteer female population: Testing the limits of the public health model
250. Attributional processes in behavior change and maintenance: Smoking cessation and continued abstinence
251. Nurse-assisted counseling for smokers in primary care
252. Evaluation of a minimal-contact smoking cessation intervention in an outpatient setting
253. Utility of behavioral self-help manuals in a minimalcontact smoking cessation program
254. The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: A randomised clinical trial
255. The role of the family physician in smoking cessation
256. Metabolites of a tobacco-specific carcinogen in urine of new-borns
257. [3H](-)nicotine binding sites in fetal human brain
258. Early developmental changes in [3H]nicotine binding in the human brainstem
259. Maternal smoking during pregnancy and the risk of conduct disorder in boys
260. Nikotine replacement therapy during pregnancy
261. Weight gain following smoking cessation
262. Weight gain and insulin resistance during nicotine replacement therapy
263. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels
264. Leptin levels in smokers and long-term users of nicotine gum
265. Smoking cessation and body mass index of occupationally active men: The Israeli CORDIS Study
266. Interaction of stress, smoking, and dietary restraint in women
267. Smoking cessation in women concerned about weight
268. Smoking cessation, weight gain, and changes in cardiovascular risk factors during menopause: The healthy women study
269. Open randomised trial of intermittent very low energy diet together with nicotine gum for stopping smoking in women who gained weight in previous attempts to quit
270. Can physical activity minimize weight gain in women after smoking cessation?
271. Comorbid cigarette and alcohol addiction: Epidemiology and treatment
272. Effect of smoking cessation counseling on recovery from alcoholism: Findings from a randomized community intervention trial
273. Mortality following inpatient addictions treatment: The role of tobacco use in a communitybased cohort
274. Nikotine dependence treatment during inpatient treatment for other addictions: A prospective intervention trial
275. An open trial of transdermal nicotine replacement therapy for smoking cessation among alcohol-and drug dependent inpatients